A Pilot Experience Using a 1-Bag Intravenous Rapid Desensitization Protocol for Chemotherapy and Biologics in a Cohort of Patients With Access to a Delabeling Pathway.

Overview of attention for article published in Journal of Investigational Allergology and Clinical Immunology, July 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 2,280 followers.

RT @MadrigalMDPhD: Proud of @pauvazrev, who shared our experience from @ICO_oncologia and @lergiabellvitge on drug desensitisation at the p…

RT @MadrigalMDPhD: Proud of @pauvazrev, who shared our experience from @ICO_oncologia and @lergiabellvitge on drug desensitisation at the p…

RT @MadrigalMDPhD: Proud of @pauvazrev, who shared our experience from @ICO_oncologia and @lergiabellvitge on drug desensitisation at the p…

RT @MadrigalMDPhD: Proud of @pauvazrev, who shared our experience from @ICO_oncologia and @lergiabellvitge on drug desensitisation at the p…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.